bupropion hydrochloride

Generic: bupropion hydrochloride

Labeler: bluepoint laboratories
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name bupropion hydrochloride
Generic Name bupropion hydrochloride
Labeler bluepoint laboratories
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

bupropion hydrochloride 150 mg/1

Manufacturer
BluePoint Laboratories

Identifiers & Regulatory

Product NDC 68001-519
Product ID 68001-519_2a90f7e8-2e30-7358-e063-6394a90a71a9
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA210497
Listing Expiration 2026-12-31
Marketing Start 2021-12-13

Pharmacologic Class

Classes
aminoketone [epc] dopamine uptake inhibitors [moa] increased dopamine activity [pe] increased norepinephrine activity [pe] norepinephrine uptake inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68001519
Hyphenated Format 68001-519

Supplemental Identifiers

RxCUI
993541 993557
UPC
0368001520041 0368001519045
UNII
ZG7E5POY8O

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bupropion hydrochloride (source: ndc)
Generic Name bupropion hydrochloride (source: ndc)
Application Number ANDA210497 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-519-03)
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-519-04)
  • 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-519-05)
source: ndc

Packages (3)

68001-519-03 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-519-03) 68001-519-04 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-519-04) 68001-519-05 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-519-05)

Ingredients (1)

bupropion hydrochloride (150 mg/1)

Linked Drug Pages (1)

BUPROPION HYDROCHLORIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2a90f7e8-2e30-7358-e063-6394a90a71a9", "openfda": {"upc": ["0368001520041", "0368001519045"], "unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993557"], "spl_set_id": ["5ccec958-998d-43a1-86fb-eb2b5e697b77"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-519-03)", "package_ndc": "68001-519-03", "marketing_start_date": "20211213"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-519-04)", "package_ndc": "68001-519-04", "marketing_start_date": "20211213"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-519-05)", "package_ndc": "68001-519-05", "marketing_start_date": "20211213"}], "brand_name": "BUPROPION HYDROCHLORIDE", "product_id": "68001-519_2a90f7e8-2e30-7358-e063-6394a90a71a9", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "68001-519", "generic_name": "BUPROPION HYDROCHLORIDE", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA210497", "marketing_category": "ANDA", "marketing_start_date": "20211213", "listing_expiration_date": "20261231"}